The Biosimilars LatAm – Mexico 2022 forum’s main focus is The Collaborative Approach which is priorly aimed at harmonizing the legal frameworks that are applicable to biosimilar drugs.
The goal is to seek and strengthen all prescription and access processes of these treatments in order to help the patients in the region.
Collaborative approaches in general, require a multidisciplinary effort and therefore all sessions presented during this forum, will provide you with a wide scope of the current status and efforts that have been made towards the improvement of the public health sector in Mexico and Latin America.
Featured panels:
– Regulatory
– Quality & Production
– Commercialization
– Innovation & Competition
Who will
you meet?
More than:
Participants
Companies
HCPs
Patients
Academy
Investors
Institutions
Associations
Service Providers
Government Agencies
Industry Executives from Latam
- Biosimilars
- Biobetters
- Biotechnology
- Biotherapeutics
- Analytical science
- Regulatory compliance
- Quality Control
- Clinical immunology
- Scientific Affairs
- Pharmacovigilance
- Research
- Regulatory
- Business Development
- Marketing
Speaker Board
Jose Juarez
Biopharma Market Leader
Rodolfo Landa
Biopharma Market Leader
Jorge Ortiz Palomino
Managing Director
Brendan Bradley
Business Development Manager
Fabricio Carneiro de Oliveira
General Manager
Angelica Meneses Acosta
Research Professor
Eduardo Valencia Rodríguez
CEO
Orlando Aguirre
Market Access & Pricing, Institutional Sales, Government Affairs & Policy HEAD
Oriana Liceth Niño Trejos
Bioprocess Coordinator
Ernesto Martínez
Technical Application Specialist Filtration
Sarfaraz Niazi
Adj. Professor
Miguel Angel Abad Hernandez
Rheumatologist
Max Sarachaga Osterwalder
Medical Director
Javier Guerra
Regional Head Latam Norte
Nicolas Estrada
Single-use Customer Applications
Helgi Jung
Head of the Department of Biopharmacy
Sergio Valentinotti
Life Science Director
Nicolas Linares
VP & GM Mexico and Central America
William Rodriguez Limas
Director of Biotechnology Development
Nestor Perez
COO and R&D Director
Sonia Mayra Pérez Tapia
Executive Director
Ricardo Castro
VP of Bioprocessing
Program at a Glance
Collaborative: Reference Authorities' Updates and Actions Towards Regulation for Biosimilars
Stay on top of the newest regulations and tendencies led by reference authorities on biosimilars regulatory frameworks
Quality and Integrity of Biopharmaceutical Products Within Production Processes
How to ensure the safety of biotech products within Production processes? Experts sharing their point of view
Commercial Measures for Biosimilars in the LatAm Markets
Commercial strategies and market dinamycs to ensure the promotionof biosimilars uptake in Mexico and LatAm
Global innovation and Competitiveness in Pharmaceuticals: Biosimilars Case Study
How to innovate in the biosimilars industry and highly competitive markets?
Full programme in the PDF Agenda
Download Agenda